KONINKLIJKE PHILIPS NVR- NY (PHG)
US5004723038
Taking everything into account, PHG scores 4 out of 10 in our fundamental rating. PHG was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHG have multiple concerns. PHG is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHG was profitable.
PHG had a positive operating cash flow in the past year.
In multiple years PHG reported negative net income over the last 5 years.
Of the past 5 years PHG 4 years had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of -1.43%, PHG is doing good in the industry, outperforming 66.84% of the companies in the same industry.
PHG has a better Return On Equity (-3.54%) than 67.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROIC | N/A |
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHG's Operating Margin has declined in the last couple of years.
PHG has a worse Gross Margin (41.56%) than 65.78% of its industry peers.
PHG's Gross Margin has been stable in the last couple of years.
PHG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% |
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%
2. Health
2.1 Basic Checks
PHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
PHG has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PHG has been increased compared to 5 years ago.
The debt/assets ratio for PHG is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.61, we must say that PHG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.61, PHG perfoms like the industry average, outperforming 55.62% of the companies in the same industry.
PHG has a debt to FCF ratio of 7.27. This is a slightly negative value and a sign of low solvency as PHG would need 7.27 years to pay back of all of its debts.
PHG has a better Debt to FCF ratio (7.27) than 73.80% of its industry peers.
PHG has a Debt/Equity ratio of 0.60. This is a neutral value indicating PHG is somewhat dependend on debt financing.
PHG has a Debt to Equity ratio of 0.60. This is in the lower half of the industry: PHG underperforms 67.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | 7.27 | ||
| Altman-Z | 1.61 |
ROIC/WACCN/A
WACC6.11%
2.3 Liquidity
PHG has a Current Ratio of 1.16. This is a normal value and indicates that PHG is financially healthy and should not expect problems in meeting its short term obligations.
PHG has a Current ratio of 1.16. This is amonst the worse of the industry: PHG underperforms 89.84% of its industry peers.
PHG has a Quick Ratio of 1.16. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
PHG has a worse Quick ratio (0.74) than 89.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
PHG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.95%.
The Earnings Per Share has been decreasing by -2.67% on average over the past years.
PHG shows a small growth in Revenue. In the last year, the Revenue has grown by 1.92%.
The Revenue has been growing slightly by 0.05% on average over the past years.
EPS 1Y (TTM)3.95%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS Q2Q%-1.93%
Revenue 1Y (TTM)1.92%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Sales Q2Q%-0.51%
3.2 Future
PHG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.13% yearly.
The Revenue is expected to grow by 4.56% on average over the next years.
EPS Next Y20.42%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
EPS Next 5Y16.13%
Revenue Next Year-0.83%
Revenue Next 2Y1.72%
Revenue Next 3Y2.71%
Revenue Next 5Y4.56%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 19.40, which indicates a rather expensive current valuation of PHG.
Based on the Price/Earnings ratio, PHG is valued cheaper than 87.70% of the companies in the same industry.
PHG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.96.
With a Price/Forward Earnings ratio of 14.98, PHG is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 90.91% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of PHG to the average of the S&P500 Index (23.82), we can say PHG is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.4 | ||
| Fwd PE | 14.98 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHG is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, PHG is valued cheaply inside the industry as 90.37% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.59 | ||
| EV/EBITDA | 30.04 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PHG's earnings are expected to grow with 15.06% in the coming years.
PEG (NY)0.95
PEG (5Y)N/A
EPS Next 2Y16.17%
EPS Next 3Y15.06%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.15%, PHG is a good candidate for dividend investing.
PHG's Dividend Yield is rather good when compared to the industry average which is at 1.68. PHG pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.23, PHG pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
5.2 History
The dividend of PHG decreases each year by -65.46%.
PHG has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-65.46%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
PHG has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-0.48%
EPS Next 2Y16.17%
EPS Next 3Y15.06%
KONINKLIJKE PHILIPS NVR- NY
NYSE:PHG (11/22/2024, 3:19:29 PM)
26.38
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap24.64B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.15% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.4 | ||
| Fwd PE | 14.98 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.95
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.43% | ||
| ROE | -3.54% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 41.56% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3.95%
EPS 3Y-15.7%
EPS 5Y
EPS Q2Q%
EPS Next Y20.42%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.92%
Revenue growth 3Y1.62%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y